Aspiriant LLC’s Keysight KEYS Stock Holding History

Aspiriant LLC’s Portfolio KEYS Stock Details KEYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$480K	Sell	1,370 -60	-4%	-$20.5K	0.01%	250
2026 Q1	$404K	Buy	+1,430	New	+$358K	0.01%	246

Other funds holding KEYS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Aspiriant LLC's KEYS Position: Q2 2026 in Review

Aspiriant LLC reduced its Keysight (KEYS) stake by 4.2% in Q2 2026, selling an estimated $20.5K and leaving 1,370 shares worth $480K. The position accounts for 0.01% of the portfolio, ranked #250.

Aspiriant LLC first reported a position in KEYS in Q1 2026 and has held it in 2 quarters since. 1,255 funds tracked by Wall St. Rank hold KEYS as of Q2 2026.

Aspiriant LLC held 1,370 shares of Keysight worth $480K as of Q2 2026.
Aspiriant LLC sold 60 Keysight shares in Q2 2026, an estimated $20.5K.
Keysight made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #250 holding.
Aspiriant LLC first reported a position in Keysight in Q1 2026 and has held it in 2 quarters since.
1,255 funds tracked by Wall St. Rank held Keysight as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.